Germany Short-read Sequencing Market Size & Outlook
Germany short-read sequencing market, 2018-2030 (US$M)
Related Markets
Germany short-read sequencing market highlights
- The Germany short-read sequencing market generated a revenue of USD 346.3 million in 2023 and is expected to reach USD 1,237.0 million by 2030.
- The Germany market is expected to grow at a CAGR of 19.9% from 2024 to 2030.
- In terms of segment, consumables was the largest revenue generating product in 2023.
- Services is the most lucrative product segment registering the fastest growth during the forecast period.
Short-read sequencing market data book summary
| Market revenue in 2023 | USD 346.3 million |
| Market revenue in 2030 | USD 1,237.0 million |
| Growth rate | 19.9% (CAGR from 2023 to 2030) |
| Largest segment | Consumables |
| Fastest growing segment | Services |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Consumables, Services |
| Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Birks Group Inc Class A, Qiagen NV, Agilent Technologies Inc, Macrogenics Inc, Azenta Inc, PerkinElmer, ProPhase Labs Inc |
Other key industry trends
- In terms of revenue, Germany accounted for 6.1% of the global short-read sequencing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany short-read sequencing market is projected to lead the regional market in terms of revenue in 2030.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 1,237.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Short-read Sequencing Market Scope
Short-read Sequencing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Germany short-read sequencing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to short-read sequencing market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 61.94% in 2023. Horizon Databook has segmented the Germany short-read sequencing market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
Germany held the largest share in the European short read sequencing market due to the presence of a range of advanced technologies, excellent genomic research, and clinical infrastructure.
In addition, Germany has institutes and universities which are involved in next-generation genomic research and investigation projects related to oncology and HLA testing. Recently a German team of scientists developed a gene panel using next-generation sequencing for diagnostic usage in chronic lymphocytic leukemia and related clinical research.
Furthermore, a significant part of the country’s GDP is spent on healthcare. The pharmaceutical and biotechnology sectors in the country have also witnessed significant growth. This, in turn, is anticipated to drive the short-read sequencing market.
Reasons to subscribe to Germany short-read sequencing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Germany short-read sequencing market databook
-
Our clientele includes a mix of short-read sequencing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany short-read sequencing market , including forecasts for subscribers. This country databook contains high-level insights into Germany short-read sequencing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Germany short-read sequencing market size, by product, 2018-2030 (US$M)
Germany Short-read Sequencing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
